 |
|
|
| |
HCV Screening/treatment in UK Prisons Can be Cost-Effective - IS INCREASED HCV CASE-FINDING COMBINED WITH 8 OR 12 WEEK INTERFERON-FREE DIRECT-ACTING ANTIVIRAL TREATMENT COST EFFECTIVE IN UK PRISONS?
A COST UTILITY ANALYSIS INCLUDING TREATMENT AS PREVENTION BENEFITS
|
| |
| |
HCV Screening/treatment in UK Prisons Can be Cost-Effective, New Modeling Study by Natasha Martin: "Scaling-up treatment to PWID could substantially increase-cost-effectiveness due to prevention benefit"
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
Natasha Martin, Associate Professor, UC San Diego
Prof Matthew Hickman & Prof Peter Vickerman, Univ of Bristol
|
| |
|
|
|
|
|
